David Liss, MD

David Liss, MD

Division Chief of Medical Toxicology; Associate Professor, Emergency Medicine


  • B.A., Northwestern University, Evanston, Illinois, 2003-2007
  • M.D., University of Illinois at Chicago – College of Medicine, 2007-2011


  • Emergency Medicine Residency, Barnes Jewish Hospital/St. Louis Children’s Hospital and Washington University School of Medicine, 2011-2015
  • Chief Residency, Emergency Medicine Residency, Barnes Jewish Hospital/St. Louis Children’s Hospital and Washington University School of Medicine, 2014-2015
  • Medical Toxicology Fellowship, Washington University School of Medicine, 2015-2017

Licensure and Board Certification

  • Permanent Medical License, Missouri Board of Registration for the Healing Arts, 2014-Present
  • Permanent Medical License, Illinois Division of Professional Regulation, 2020-Present
  • Board Certified in Emergency Medicine, American Board of Emergency Medicine, 2016-Present
  • Board Certified in Medical Toxicology, American Board of Emergency Medicine, 2018-Present
  • Board Certified in Addiction Medicine, American Board of Preventive Medicine, 2022-Present

Honors and Awards

  • Emergency Medicine Residency Toxicology Award 2014
  • Emergency Medicine Residency Pediatrics Award 2015
  • Emergency Medicine Golden Apple Teaching Award 2017

Recent Publications

  1. Liss DB, Mullins ME. Antithrombotic and Antiplatelet Drug Toxicity. Crit Care Clin. 2021 Jul;37(3):591-604. PMID: 34053708. 
  2. Kessler SH, Schwarz ES, Liss DB. Methadone vs. Buprenorphine for In-Hospital Initiation: Which Is Better for Outpatient Care Retention in Patients with Opioid Use Disorder? J Med Toxicol. 2022 Jan;18(1):11-18. Epub 2021 Sep 23. PMID: 34554396. 
  3. Winograd RP, Coffey B, Woolfolk C, Wood CA, Ilavarasan V, Liss D, Jain S, Stringfellow EJ. To prescribe or not to prescribe?: Barriers and motivators for progressing along each stage of the buprenorphine training and prescribing path. J Behav Health Serv Res. 2022 Jan. https://doi.org/10.1007/s11414-021-09783-z 
  4. Liss DB, Roper SM, Dietzen DJ, Mullins ME. In-vitro study of lithium binding by sodium zirconium cyclosilicate (Lokelma®) or patiromer (Veltassa®). Toxicology Communications, 2021;5(1): 161-164. 
  5. Marks LR, Reno H, Liang SY, Schwarz ES, Liss DB, Jiang L, Nolan NS, Durkin MJ. Value of Packaged Testing for Sexually Transmitted Infections for Persons who Inject Drugs Hospitalized With Serious Injection-Related Infections. Open Forum Infect Dis. 2021 Nov 11;8(11):ofab489. PMID: 34926711. 
  6. Baumgartner K, Salmo E, Liss D, Devgun J, Mullins M, Galati B, Kelly J, Schwarz E. Transdermal buprenorphine for in-hospital transition from full agonist opioids to sublingual buprenorphine: a retrospective observational cohort study. Clin Toxicol (Phila). 2022 Jan 20:1-6. Epub ahead of print. PMID: 35048759. 
  7. Lewis S, Liang SY, Schwarz ES, Liss DB, Winograd RP, Nolan NS, Durkin MJ, Marks LR. Patients With Serious Injection Drug Use-Related Infections who Experience Patient-Directed Discharges on Oral Antibiotics Have High Rates of Antibiotic Adherence but Require Multidisciplinary Outpatient Support for Retention in Care. Open Forum Infect Dis. 2022 Jan 6;9(2): PMID: 35106316 
  8. Mullins ME, Schwarz ES, Liss DB, Baumgartner KT, Devgun JM. How Should Native Crotalid Envenomation Be Managed in the Emergency Department? J Emerg Med. 2022 Jan;62(1):131-132. PMID: 35090730. 
  9. Mullins ME, Liss DB, Schwarz ES, Arroyo-Plasencia A. 61-year-old woman, nausea, paresthesia, cold allodynia, Dx? J Fam Pract. 2022 Apr;71(3):138-140. PMID: 35561236. 
  10. Stephens RJ, Filip AB, Baumgartner KT, Schwarz ES, Liss DB. Benzonatate Overdose Presenting as Cardiac Arrest with Rapidly Narrowing QRS Interval. J Med Toxicol. 2022 Jul 5. Epub ahead of print. PMID: 35790679.